# Clinical Experimentation With Tenofovir Disoproxyl Fumarate and Emtricitabine for COVID-19

> **NCT04712357** · NA · UNKNOWN · sponsor: **Universidade Federal do Ceara** · enrollment: 219 (estimated)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Vitamin C 500 MG Oral Tablet
- **DRUG:** Tenofovir disoproxyl fumarate 300 MG Oral Tablet
- **DRUG:** Tenofovir disoproxyl fumarate 300 MG plus emtricitabine 200 MG Oral Tablet

## Key facts

- **NCT ID:** NCT04712357
- **Lead sponsor:** Universidade Federal do Ceara
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-09
- **Primary completion:** 2022-01
- **Final completion:** 2023-01
- **Target enrollment:** 219 (ESTIMATED)
- **Last updated:** 2021-01-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04712357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04712357, "Clinical Experimentation With Tenofovir Disoproxyl Fumarate and Emtricitabine for COVID-19". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04712357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*